Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-27

Clinical Trial Update: A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating roxadustat to treat anemia in children and adolescents with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roxadustat (roxadustat)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Chronic Kidney Disease, Renal Anemia | Phase 3 | Status: RECRUITING